Immunome (IMNM) Other Working Capital Changes (2019 - 2026)

Immunome has reported Other Working Capital Changes for 8 years, with the latest figure at $5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 4487.42% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.1 million (up 11671.8% YoY), and the FY2025 full-year result was $237184.0, down 39.26% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $5.1 million, up from $42000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $27.6 million in Q1 2023, with the low at -$23000.0 in Q2 2022.
• Historically, Other Working Capital Changes has averaged $2.5 million across 5 years, with a median of $165000.0 in 2022.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 101.06% — and 2023, when it jumped 153633.33%.
• Immunome's Other Working Capital Changes stood at $165000.0 in 2022, then surged by 933.94% to $1.7 million in 2023, then jumped by 265.53% to $6.2 million in 2024, then tumbled by 99.33% to $42000.0 in 2025, then jumped by 12038.1% to $5.1 million in 2026.
• The last three Other Working Capital Changes figures came in at $5.1 million (Q1 2026), $42000.0 (Q4 2025), and $237184.0 (Q3 2025), per Business Quant data.